Beijing CELLada Biotechnology Co., Ltd.
CELLada is a cutting-edge bio-based company focusing on organoid technology. The company has built a complete organoid industrial chain with an organoid culture system for organs and tissues such as lungs, pancreas, islet, intestine, bile duct, liver, etc. With a high-throughput tumor organoid drug screening platform for scientific research and clinical precision treatment, CELLada is committed to R&D and production of various organoids, customized organoid chips, kits, precision medicine, regenerative medicine, new drugs and smart cell culture, and also provides a variety of in vitro CRO services. The company boasts high-caliber managerial and scientific research teams, and regards promoting the development of regenerative medicine as its mission while striving to make contributions to human health.